FMII
GPCR icon

Farmers & Merchants Investments Inc’s Structure Therapeutics GPCR Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-100
Closed -$4.82K – 1788
2026
Q1 		$4.82K Buy
+100
New +$6.84K ﹤0.01% 981

Other funds holding GPCR

Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Farmers & Merchants Investments Inc's GPCR Position: Q2 2026 in Review

Farmers & Merchants Investments Inc sold out of Structure Therapeutics (GPCR) in Q2 2026, closing a stake of 100 shares — an estimated $4.82K sold.

Farmers & Merchants Investments Inc first reported a position in GPCR in Q1 2026 and held it in 1 quarter. The position peaked at $4.82K in Q1 2026. 58 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Farmers & Merchants Investments Inc reported no remaining Structure Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Farmers & Merchants Investments Inc sold 100 Structure Therapeutics shares in Q2 2026, an estimated $4.82K.
  • Farmers & Merchants Investments Inc first reported a position in Structure Therapeutics in Q1 2026 and held it in 1 quarter.
  • Farmers & Merchants Investments Inc's Structure Therapeutics position peaked at $4.82K in Q1 2026.
  • 58 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Farmers & Merchants Investments Inc's 13F filing for Q2 2026, filed 20 Jul 2026.